Boussard & Gavaudan Investment Management LLP Laboratory Corp Of America Holdings Transaction History

Boussard & Gavaudan Investment Management LLP

$407 Million
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$201.05 - $221.7 $7.54 Million - $8.31 Million	-37,494 Reduced 75.26%	12,322 $2.48 Million
Q2 2023 Aug 11, 2023	BUY	$211.93 - $241.33 $10.6 Million - $12 Million	49,816 New	49,816 $12 Million
Q2 2022 Aug 10, 2022	SELL	$213.86 - $277.87 $13.1 Million - $17 Million	-61,104 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$259.82 - $298.18 $12.9 Million - $14.8 Million	-49,523 Reduced 44.77%	61,104 $16.4 Million
Q4 2021 Feb 10, 2022	SELL	$271.6 - $314.21 $1.48 Million - $1.71 Million	-5,432 Reduced 4.68%	110,627 $34.7 Million
Q2 2021 Aug 06, 2021	BUY	$251.87 - $278.14 $29.2 Million - $32.3 Million	116,059 New	116,059 $31.7 Million

Others Institutions Holding LH

# of Institutions

Shares Held

1.94M

Call Options Held

Put Options Held

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boussard & Gavaudan Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Boussard & Gavaudan Investment Management LLP with notifications on news.

Account